BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26676639)

  • 1. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
    Ma S; Yang J; Li J; Song J
    Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
    Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
    Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic analysis of hepatocellular carcinoma based on the tumor neo-vessels, macrophages and α-SMA in tumor microenvironment].
    Fang M; Yuan JP; Liu LL; Cheng GP; Ying HJ; Chen YM; Chen M
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):518-523. PubMed ID: 28728298
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
    Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
    Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
    Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
    Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.
    Kitamoto M; Nakanishi T; Kira S; Kawaguchi M; Nakashio R; Suemori S; Kajiyama G; Asahara T; Dohi K
    Cancer; 1993 Sep; 72(6):1859-65. PubMed ID: 8103417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
    Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
    Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
    Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
    BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.